NEWS:

 “THE internet is stuffed with garbage. Anti-vaccination websites make the front page of Google, and fact-free ‘news’ stories spread like wildfire. Google has devised a fix – rank websites according to their truthfulness.”

Great idea, right?

Sure it is.

The author of the article lets the cat out of the bag right away with his comment about “anti-vaccination” websites.

These sites will obviously be shoved into obscurity by Google because they’re “garbage”…whereas “truthful” pro-vaccine sites will dominate top ranked pages on the search engine.

 

http://www.activistpost.com/2015/03/google-gives-new-meaning-to-orwellian.html

 “A Google research team is adapting [a] model to measure the trustworthiness of a [website] page, rather than its reputation across the web. Instead of counting incoming links, the [ranking] system – which is not yet live – counts the number of incorrect facts within a page. ‘A source that has few false facts is considered to be trustworthy,’ says the team…The score they compute for each page is its Knowledge-Based Trust score.”

 

 

 

“The [truth-finding] software works by tapping into the Knowledge Vault, the vast store of facts that Google has pulled off the internet. Facts the web unanimously agrees on are considered a reasonable proxy for truth. Web pages that contain contradictory information are bumped down the rankings.”

http://www.mrc.org/articles/debate-over-dress-color-gets-3x-more-network-attention-net-neutrality-ruling

 A 20-year-old Alabama man won a lawsuit against Janssen Pharmaceuticals (a Johnson & Johnson subsidiary) after an antipsychotic drug caused him to develop size 46DD breasts. He was awarded $2.5 million in damages on Tuesday in a Philadelphia court

 

 

 

Austin Pledger reportedly took an antipsychotic drug known as Risperdal as a child and wasn’t “adequately warned” he would grow breasts as a side effect, his lawyer Thomas Kilne stated. Pledger, who has autism, was first prescribed the drug in 2002, back when Risperdal was not yet approved by the U.S. Food and Drug Administration (FDA) to be used in children. He was 8 years old at the time.

The drug’s label said that the risk of gynecomastia — the condition of men growing female breasts — was low. But by 2006, after the FDA had approved the drug for use in children with both schizophrenia and bipolar disorder problems, the label changed to report high levels of prolactin, a hormone that aids in breast growth, Kline said.

When the FDA revised the label, Pledger was 12 and already starting to develop breasts. And the only way they could be removed was through a mastectomy.

Janssen was “disappointed” in the court’s decision, however, claiming that the drug’s side effects were clear for Pledger’s family and physician, according to a spokeswoman. Pledger’s “quality of life was significantly improved during the time he was taking Risperdal,” she argued in a statement. But the judge didn’t seem to pay heed to the company’s plea.

 

SHOW NOTES:

 Thank you for listening! Please comment below!